tradingkey.logo
tradingkey.logo
Search

SpyGlass Pharma Ord shs (Proposed)

SGP
Add to Watchlist
19.150USD
-0.320-1.64%
Close 07/02, 13:00ETQuotes delayed by 15 min
611.10MMarket Cap
LossP/E TTM
You can find the annual or quarterly income statement of SpyGlass Pharma Ord shs (Proposed) here for insights into the performance and operational efficiency of SpyGlass Pharma Ord shs (Proposed).
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating expenses
--15.41M
R&D expenses
--8.24M
Depreciation, depletion, and amortization
--318.00K
Operating profit
---15.41M
Net non-operating interest income (expenses)
Non-operating interest income
--1.59M
Special income (expenses)
--0.00
Income before tax
---13.82M
Income tax
--0.00
Income after tax
---13.82M
Net income from continuous operations
---13.82M
Net income attributable to controlling interests
---13.82M
Net income attributable to common shareholders
---13.82M
Basic earnings per share
---0.69
Diluted earnings per share
---0.69
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--

FAQs

What is the income statement?

The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.